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Accepted 12 November 2015The antihypertensive drugs moxonidine and clonidine areα2-adrenoceptor and imidazoline (I1) agonists. Previ-
ous results from our laboratory have shown that moxonidine can act in the commissural nucleus of the solitary
tract (commNTS). In addition, some studies have shown that GABA or glutamate receptor blockade in the RVLM
blunted the hypotension produced by these antihypertensive agents in spontaneously hypertensive rats. There-
fore, in the present studywe verifywhether the cardiovascular and sympathetic effects produced bymoxonidine
in the commNTS are dependent on GABAergic or glutamatergic mechanisms. Mean arterial pressure (MAP) and
splanchnic sympathetic nerve activity (sSNA)were recorded in urethane-anesthetized, and artiﬁcially-ventilated
maleWistar rats (250–350 g). Injection of the GABAA antagonist bicuculline (25 pmol/50 nL) into the commNTS
reduced the hypotension as well as the sympathoinhibition elicited by moxonidine. Prior injection of the gluta-
mate receptor antagonist kynurenic acid (2.5 nmol/50 nL) into the commNTS was not effective in reducing the
hypotension and sympathoinhibition elicited by moxonidine. Therefore, we conclude that the hypotensive and
sympathoinhibitory effects elicited by microinjection of moxonidine into the commNTS are dependent on
GABA receptors, but not ionotropic glutamate receptors.
© 2015 Elsevier B.V. All rights reserved.Keywords:
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It is well established that the nucleus of the solitary tract (NTS) is
considered the site of the ﬁrst synapse of the visceral sensory inputs
to the brainstem (Dampney, 1994; Guyenet, 2006). One of the neuro-
transmitter released by these afferents in the NTS is the L-glutamate
(Talman et al., 1980; Dampney, 1994). Anatomical and immunohisto-
chemical studies have shown that, besides the baroreﬂex pathway, the
NTS sends monosynaptic inputs to the rostral ventrolateral medulla/
C1 region (RVLM/C1) (Hancock, 1988; Morilak et al., 1989; Otake
et al., 1992) and these projections may convey peripheral chemorecep-
tor signals (Colombari et al., 1996; Koshiya and Guyenet, 1996). The ex-
istence of pressormechanisms in theNTS is supported by the increase in
arterial pressure produced by L-glutamate injections into the NTS in
conscious rats (Machado and Bonagamba, 1992; Colombari et al., 1994).y and Biophysics, Institute of
900 São Paulo, SP, Brazil.
udy.The NTS and the RVLM/C1 are considered the main brainstem re-
gions of centrally acting antihypertensive drugs (Ernsberger et al.,
1997; Guyenet, 1997; Ernsberger and Haxhiu, 1997; Totola et al.,
2013). Preliminary results from our laboratory depicted that
moxonidine act on α2-adrenoceptors (α2-AR) in the commissural as-
pect of the NTS (commNTS) to produce hypotension and
sympathoinhibition in anesthetized and conscious rats (Totola et al.,
2013).
Besides the α2-adrenergic mechanisms related to the action of anti-
hypertensive drugs such as moxonidine and clonidine, several studies
have indicated that several neurotransmitters such as GABA (γ-
aminobutyric acid) and glutamate are involved in the
sympathoinhibition and hypotension elicited by moxonidine or cloni-
dine (Tingley and Arnerić, 1990; Milhaud et al., 2000). Considering the
existing evidence, our hypothesis is that GABAergic and glutamatergic
mechanismmight be responsible to the antihypertensive effects elicited
by moxonidine into commNTS. However, due to the importance of
GABAaswell as glutamate receptors into theNTS for cardiovascular reg-
ulation, it might be interesting to investigate whether GABAergic and
glutamatergic mechanisms are also important to mediate the antihy-
pertensive effects of moxonidine into the commNTS.
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2.1. Animals
Experiments were performed in 37 adult maleWistar rats weighing
280–320 g. All experimental protocols were in accordancewith the Eth-
ical Principles in Animal Research of the Brazilian College of Animal Ex-
perimentation (CONCEA) and were approved by the Ethics Committee
for Animal Research of the Institute of Biomedical Sciences of the Uni-
versity of Sao Paulo (CEUA: Authorization No. 85/2010).
2.2. Surgery and anesthesia
Rats were deeply anesthetized with halothane (5% in 100% oxygen
inspired air) for general surgical procedures, such as: a) tracheostomy
for artiﬁcial ventilation; b) femoral artery and vein catheterization for
arterial pressure measurement and administration of ﬂuids and drugs,
respectively; c) intraparenchymal injection by removal of the occipital
bone and retracting the underlying dura-mater membrane for insertion
of a pipette into the medulla oblongata via a dorsal transcerebellar ap-
proach (Takakura and Moreira, 2011); d) splanchnic sympathetic
nerve isolation for subsequent nerve activity monitoring. The level of
anesthesia was checked by a ﬂexor reﬂex to the animal's paw pinching.
Splanchnic sympathetic nerve activity (sSNA) was recorded as pre-
viously described (Takakura and Moreira, 2011). Brieﬂy, the right
splanchnic nerve was isolated via a retroperitoneal approach, and the
segment distal to the suprarenal ganglion was placed on a pair of
Teﬂon-coated silver wires that had been bared at the tip (250 μm bare
diameter; A-M Systems, www.amsystems.com). The nerves and wires
were embedded in adhesivematerial (Kwik-Cast Sealant,WPI, USP, Sar-
asota, FL, USA), and the woundwas closed around the exiting recording
wires.
Upon completion of the surgical procedures, halothanewas replaced
by urethane (1.2 g/kg of body weight) slowly administered intrave-
nously (i.v.). All rats were artiﬁcially ventilated with 100% oxygen
throughout the experiment. The rectal temperature was maintained at
37 °C and the end tidal-CO2weremonitored throughout the experiment
with a capnometer (CWE, Inc., Ardmore, PA, USA) that was calibrated
twice per experiment against a calibrated CO2/N2mix. The adequacy of
the anesthesia was monitored during a 20-min stabilization period by
testing for the absence of withdrawal response and the lack of arterial
pressure change to ﬁrm toe pinch. After these criteria were satisﬁed,
the muscle relaxant pancuronium was administered at the initial dose
of 1 mg/kg i.v. and the adequacy of anesthesia was thereafter gauged
solely by the lack of increase in arterial pressure to ﬁrm toe pinch. Ap-
proximately hourly supplements of one-third of the initial dose of ure-
thane were needed to satisfy these criteria during the course of the
recording period (80 min).
2.3. In vivo recordings of physiological variables
Mean arterial pressure (MAP) and the discharge of the splanchnic
nerve (sSNA) and the tracheal CO2 were recorded as previously de-
scribed (Taxini et al., 2011). Before starting the experiments, the venti-
lation was adjusted to have the end-expiratory CO2 at 3–4% at steady-
state (60–80 cycles/s; tidal volume 1–1.2 ml/100 g). All analog data
(end-expiratory CO2, MAP and sSNA) were stored on a computer via a
micro 1401 digitizer (Cambridge Electronic Design, Cambridge, UK)
and were processed off-line using version 6 of the Spike 2 software
(Cambridge Electronic Design) as described previously (Takakura and
Moreira, 2011; Taxini et al., 2011). The integrated splanchnic nerve ac-
tivity (iSNA) was obtained after the rectiﬁcation and smoothing (σ=
2 s) of the original signal, which was acquired with a 30–3000 Hz
band pass. The iSNA was normalized for each animal by assigning the
value of 100 to the resting SNA and the value of 0 to the minimumvalue recorded after the administration of the ganglionic blockade
(hexamethonium: 30 mg/kg, i.v.).
2.4. Intraparenchymal injections
All drugswere purchased fromSigma-Aldrich (SigmaChemicals Co.)
unless otherwise stated. Bicuculline methiodide (Bic: 25 pmol/50 nL),
kynurenic acid (kyn: 2.5 nmol/50 nL) and moxonidine hydrochloride
(moxo: 5 nmol/50 nL in sterile saline pH 7.4) were pressure injected
(Picospritzer III, Parker Hanniﬁn Corp, USA) (50 nL in 5 s) through
single-barrel glass pipettes (20 μm tip diameter). Injections into the
commNTS were made 400 μm caudal to the calamus scriptorius, in the
midline and 0.3 to 0.5 mm below the dorsal surface of the brainstem.
A mix of propylene glycol/water 2:1 was used as vehicle for bicuculline
andmoxonidine because these drugs are not soluble in saline. The solu-
tion of moxonidine, bicuculline and kynurenic acid contained a 5% dilu-
tion of ﬂuorescent latex microbeads (Lumaﬂuor, New City, NY, USA) for
later histological identiﬁcation of the injection sites (Takakura and
Moreira, 2011; Takakura et al., 2011).
2.5. Histology
At the endof the experiment, the ratswere deeply anesthetizedwith
urethane and perfused through the heart with PBS (pH 7.4) followed by
paraformaldehyde (4% in 0.1 M phosphate buffer, pH 7.4). The brains
were removed and stored in ﬁxative for 24 h at 4 °C. The medulla was
cut in 40 μm thick coronal sections with a vibrating microtome
(Vibratome 1000S Plus, USA). Sections were stored at−20 °C in a cryo-
protectant solution (Schreihofer and Guyenet, 1997). The injections
sites were conﬁrmed with an Axioskop 2 microscope (Zeiss,
Oberkochen, Germany). The section alignment between the brains
was done relative to a reference section. To align the sections around
NTS level, the mid-area postrema level was identiﬁed in each brain
and assigned the level 13.8 mm (Bregma−13.8 mm) according to the
atlas of Paxinos and Watson (1998). The coordinates of sections rostral
and caudal of this reference section were calculated with respect to the
reference section, using the number of intervening sections and the sec-
tion thickness.
2.6. Experimental protocol
2.6.1. Effects of the combination of bicuculline andmoxonidine injected into
the commNTS on arterial pressure and sympathetic outﬂow
All experiments were performed in rats anesthetized with urethane
(1.2 g/kg, i.v.). Recordings began 10 min after the connection of the ar-
terial line to the pressure transducer. MAP and sSNAwere continuously
recorded for 80min andwere analyzed every 10min. Control (baseline)
valueswere recorded for 10min andwere analyzed immediately before
the bicuculline (25 pmol/50 nL) or vehicle injection (ﬁrst treatment).
These valueswere used as a reference to calculate the changes produced
by the treatments. After 10 min, moxonidine (5 nmol/50 nL) or vehicle
was injected into the commNTS and theMAP and sSNA responses were
evaluated for the next hour.
2.6.2. Effects of the combination of kynurenic acid and moxonidine injected
into the commNTS on arterial pressure and sympathetic outﬂow
All experiments were performed in rats anesthetized with urethane
(1.2 g/kg, i.v.). Recordings began 10 min after the connection of the ar-
terial line to the pressure transducer. MAP and sSNAwere continuously
recorded for 80min andwere analyzed every 10min. Control (baseline)
valueswere recorded for 10min andwere analyzed immediately before
the kynurenic acid (2.5 nmol/50 nL) or vehicle injection (ﬁrst treat-
ment). These values were used as a reference to calculate the changes
produced by the treatments. After 10 min, moxonidine (5 nmol/50 nL)
or vehicle was injected into the commNTS and the MAP and sSNA re-
sponses were evaluated for the next hour.
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Statistical analysis was donewith Sigma Stat version 3.0 (Jandel Cor-
poration, Point Richmond, CA). Data are reported as means ± SEM.
Two-way parametric ANOVA followed by the Newman-Keuls multiple
comparisons test were used as appropriate. Signiﬁcance was set at
p b 0.05.3. Results
3.1. Histological analysis
Injections into the commNTS were located about 400 μm caudal to
the calamus scriptorius as illustrated in Figs. 1A and 1B. A single injection
was administered in or near themidline as represented in Figs. 1A-B, 2D
and 3D. Based on the area of the distribution of the beads, the injectate
spread bilaterally (approximately 500 μmfrom the injection center) and
a little less in the rostrocaudal direction (approximately 300 μm from
the injection center). The effective spread of the drugs was not deter-
mined and could have been larger than that of the microbeads due to
the difference in molecular mass.Fig. 1. Photomicrographs of typical midline injection into the commNTS in anesthetized
rat (arrow). A) Nissl staining and B) ﬂuorescent microbeads. Scale bar in B = 1 mm
apply to all panels. Abbreviations: cc: central canal; Gr: gracile nucleus; XII: hypoglossal
nucleus.3.2. Effects of moxonidine injection into the commNTS in rats previously
treated with bicuculline
The ﬁrst set of experiments was designed to test the involvement of
GABAergic mechanisms within the commNTS in the hypotension and
sympathoinhibition elicited by moxonidine in rats. Bicuculline (25
pmol/50 nL) injected into the commNTS reduced moxonidine-induced
(5 nmol/50 nL) hypotension (104 ± 2, vs. moxonidine: 89 ±
7 mm Hg) [F(3, 41) = 57.13, p = 0.034] and sympathoinhibition
(Δ=−13 ± 3% vs. moxonidine: Δ=−24 ± 2% of inhibition) [F(3,
41) = 62.34, p = 0.028] (Fig. 2A–C). Bicuculline injected into the
commNTS produced no change in the restingMAP (119± 6 vs vehicle:
117± 5mmHg, p= 0.42) and resting sSNA (2± 5, vs vehicle: 9 ± 7%,
p = 0.55) (Fig. 2A–C).
3.3. Effects of moxonidine injection into the commNTS in rats previously
treated with antagonist of glutamatergic ionotropic receptors
The next experiments attempted to evaluate the glutamatergic par-
ticipation on cardiovascular and sympathetic effects elicited by
moxonidine within the commNTS.
Pre-treatment with the broad spectrum ionotropic antagonist
kynurenic acid (2.5 nmol/50 nL) into commNTS was not effective to at-
tenuate the hypotension (Δ=−24 ± 3, vs. moxonidine: Δ=−25 ±
9 mm Hg) [F(1, 28) = 0,18, p = 0.642] and sympathoinhibition
(Δ=−22 ± 5% vs. moxonidine: Δ=−28 ± 9% of inhibition) [F(1,
28) = 0057, p = 0.62] elicited by moxonidine (5 nmol/50 nL) into
commNTS. The injection of kynurenic acid into commNTS produced
no change in baseline MAP (Δ = 2 ± 4, vs. vehicle: Δ = 7 ±
4 mm Hg) F(1, 28) = 0,0012, p = 0.078], and SNA (Δ= 8± 5, vs. ve-
hicle: Δ= 7± 2%) [F(1, 28) = 0,03, p = 0.4] (Fig. 3A–C).
The lack of effect produced by a high dose of kyn prompted us to ver-
ify that identical injections of kyn could block the baroreﬂex-induced
sympathoinhibition in response to intravenous (iv) injection of phenyl-
ephrine (5 μg/kg). For example, injection of kyn in the commNTS in 4
urethane anesthetized rats blocked the sympathoinhibitory effect
(3± 3%, vs. saline:−81±9% of inhibition) (p b 0.001) elicited by iv in-
jection of phenylephrine (data not shown).
Figs. 2D and 3D represents the injections that were located outside
the commNTS region and these injections often reached the hypoglossal
motor nucleus (7of 11) or the gracile nucleus (4 of 11). Injections of
moxonidine (5 nmol/50 nL) outside the commNTS (n = 11) produced
no signiﬁcant changes in the resting MAP (106 ± 4, vs. vehicle:
109 ± 6 mm Hg) [F(1, 24) = 0.18, p = 0.43] and sSNA (Δ= −1 ±
4% vs. vehicle: Δ=2± 3%) [F(1, 24) = 0.46, p = 0.07] in anesthetized
rats.
4. Discussion
The present study showed at least two important ﬁndings. First, the
hypotensive and sympathoinhibitory effects elicited by moxonidine
into the commNTS were signiﬁcantly attenuated by the pre-treatment
with bicuculline, a GABAA receptor antagonist. Second, previous injec-
tion of kynurenic acid was not effective to attenuate the decrease in
MAP and sSNA produced by moxonidine. Based on the above evidence,
it might be suggested that the cardiovascular and sympathetic effects
elicited bymoxonidine is dependent on GABAergic, but not glutamater-
gic mechanisms at the level of the commNTS.
4.1. Brainstem areas and the α2 and imidazoline compounds
The NTS acts as the gateway to central nervous system for sensory
information arising from internal organs. Neuroanatomical studies
have shown that NTS integrates different types of sensory afferents
and connects with other pontomedullary areas. Among many neuro-
transmitters and neuromodulators present at the level of the NTS,
Fig. 2. Cardiovascular and sympathetic responses produced by combining moxonidine with bicuculline into the commNTS in urethane-anesthetized rats. (A) Recordings showing the
changes in arterial pressure (AP) and splanchnic sympathetic nerve activity (sSNA) from rats treated with injections of saline + vehicle, saline + moxonidine (5 nmol/50 nL), and
bicuculline (25 pmol/50 nL)+moxonidine into commNTS. B) and C) changes inmean arterial pressure (MAP) and sSNA, respectively, produced by injection of bicuculline or saline com-
bined with moxonidine or vehicle injected into the commNTS in urethane-anesthetized rats. D) The center of injections into the commNTS in different rats tested is depicted in a single
section (bregma=−14.3mm, according to Paxinos andWatson, 1998). Scale= 1mm. Abbreviations: cc, central canal; Gr, gracile nucleus; py, pyramide; Sp5, spinal trigeminal tract; XII,
hypoglossal nucleus. Results in B–C are reported as means± SEM. *Different from vehicle (p b 0.05), +Different from saline+moxonidine 2-way ANOVAwith the Newman–Keuls post
hoc test; N = 5–6/group of rats.
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arterial pressure (Carrettiero et al., 2012). The NTS contains a large
number of catecholaminergic neurons and different subclasses of α-
adrenergic receptors, such as α1-and α2-ARs (Duale et al., 2007;
Carrettiero et al., 2012). Previous study from our laboratory showed
that moxonidine injected in the commNTS produced a reduction in ar-
terial pressure and sympathetic outﬂow and the pre-treatmentwith yo-
himbine or RX821002, speciﬁc α2-AR antagonists, abolished the
hypotension and the sympathoinhibition by moxonidine, suggesting
the involvement of central α2-AR in these responses at the level of the
commNTS (Totola et al., 2013). The activation of α2-AR may attenuate
the activity of second-order commNTS neurons leading to an inhibition
of the presympathetic RVLM/C1 neurons.
Centrally antihypertensive drugs have been used as a pharmacolog-
ical treatment to reduce blood pressure (Edwards et al., 2012). Many
brainstem, spinal cord and forebrain regions have been suggested to
be crucialwhere clonidine ormoxonidine-like drugs inﬂuence the auto-
nomic nervous system (Isaac, 1980; Head et al., 1998; Totola et al.,
2013). The NTS and RVLM/C1 regions are the main sites of action of
these drugs (Lipski et al., 1976; Bousquet et al., 1981; Dominiak, 1994;
Guyenet, 1997; Ernsberger et al., 1997; Hayar and Guyenet, 2000;
Totola et al., 2013). The latter is considered to be the main region that
sends sympathetic efferent projections to spinal cord and has beenshown to contain imidazoline (I1R) receptors as well as α2-AR (Kino
et al., 2005). Previous studies have proposed thatα2-AR and I1R agonists
act in separate brain regions to produce the antihypertensive effects, i.e.
the I1R in theRVLM/C1 andα2-AR in theNTS, however, we can not ruled
out an effect of moxonidine on I1R at the level of the NTS (Head et al.,
1997; Guyenet, 1997; Ernsberger et al., 1997; Carrettiero et al., 2012).
5. GABA mechanisms: cardiovascular and sympathetic effects of
moxonidine
GABAergic mechanism appears to be involved in mediating the ef-
fects of central antihypertensive drugs (Jastrzebski et al., 1995; Zhang
and Abdel-Rahman, 2002; Wang et al., 2007a, 2007b). In addition,
GABAergic neurotransmission are proposed to play an important role
in the hypotension and sympathoinhibition mechanisms of clonidine
(Goźlińska and Czyzewska-Szafran, 1999). It was demonstrated in cats
that microinjections of clonidine were more effective when injected in
caudal regions of the ventrolateral medulla, i.e. in a region that contains
the bulk of GABA neurons involved in the inhibition of presympathetic
neurons of the RVLM/C1 region (Gatti et al., 1988; Cravo et al., 1991;
Schreihofer and Guyenet, 2003). The results obtained by Marmo et al.
(1987) indicate that GABAA receptor antagonist bicuculline was able
to decrease the antihypertensive effects of clonidine in Wistar Kyoto
Fig. 3. Cardiovascular and sympathetic responses produced by combining moxonidine with kynurenic acid into the commNTS in urethane-anesthetized rats. (A) Recordings showing the
changes in arterial pressure (AP) and splanchnic sympathetic nerve activity (sSNA) from rats treated with injections of vehicle + saline, vehicle + moxonidine (5 nmol/50 nL) or
kynurenic acid (2.5 nmol/50 nL) + moxonidine into commNTS. B) and C) Changes in mean arterial pressure (MAP) and sSNA, respectively, produced by injection of kynurenic acid or
vehicle combined with moxonidine (5 nmol/50 nl) injected into the commNTS in urethane-anesthetized rats. D) The center of injections into the commNTS in different rats tested is
depicted in a single section (bregma=−14.3mm, according to Paxinos andWatson, 1998). Scale= 1mm. Abbreviations: cc, central canal; Gr, gracile nucleus; py, pyramide; Sp5, spinal
trigeminal tract; XII, hypoglossal nucleus. Results in B–C are reported as means ± SEM. N = 5–6/group of rats.
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GABAergic receptors within the commNTS could mediate the hypoten-
sive and sympathoinhibition effects elicited by moxonidine. Nonethe-
less, the mechanisms responsible for the antihypertensive effects are
still unknown, but it is plausible that the antihypertensive action of
moxonidine relies on the GABAA receptor stimulation (Goźlińska and
Czyzewska-Szafran, 1999), which directly or indirectly yields reduction
in MAP and SNA.
Clonidine, anα2-AR and I1R agonist, evoked the release of inhibitory
neurotransmitters such asGABA to hyperpolarize the RVLM/C1 neurons
(Sun and Reis, 1995). In the present study, we suggest that moxonidine
could act on postsynaptic α2-AR, which is coupled to an inhibitory G
protein (Gi), leading to an inhibition of a cAMP-dependent protein ki-
nase A (PKA) compromising the proper function of the cellular machin-
ery. In addition, moxonidine could also act on presynaptic α2-AR,
recruiting GABAergic transmission. We believe that, at the level of the
commNTS, the activation of the mechanisms proposed above would
be involved to trigger the reduction of commNTS activity, leading to a
decrease in the downstream presympathetic neurons in the RVLM/C1
region. This notion could be certainly extended to many other brain re-
gions that contribute to the sympathetic outﬂow and have a high densi-
ty of GABAergic receptors such as the paraventricular nucleus of the
hypothalamus and dorsolateral pons. Therefore, more studies arenecessary to improve the understanding of the central mechanisms
involved on moxonidine-induced cardiovascular and sympathetic
responses.6. Glutamatergic mechanisms: cardiovascular and sympathetic ef-
fects of moxonidine
Besides GABAergic mechanisms, others have also suggested the role
of glutamate receptors on cardiovascular effects of clonidine and
moxonidine (Lin et al., 2004). Previous studies already demonstrated
that antagonism of N-methyl-D-aspartate receptor (NMDA) into
RVLM/C1 regionwasable toblunt thehypotensionand sympathoinhibition
induced by rilmenidine in normotensive and hypertensive rats
(Zhang and Abdel-Rahman, 2002; Wang et al., 2003, 2004). Because
the NTS is an important brainstem region for the antihypertensive ef-
fects elicited bymoxonidine (Totola et al., 2013) and it iswell established
the role of glutamatergic neurotransmission into NTS in cardiovascular
regulation, we also investigated the role of glutamate receptors in the
NTS on the cardiovascular and sympathetic responses elicited by
moxonidine. The literature showed that the glutamatergic neurotrans-
mission is crucial for the antihypertensive effects elicited by central anti-
hypertensive drugs (Wang et al., 2003, 2004), however, at the level of the
6 T.B. Alves et al. / Autonomic Neuroscience: Basic and Clinical 194 (2016) 1–7commNTS, the pre-treatment of kynurenic acidwas not effective to blunt
the hypotension and the sympatholytic effects produced bymoxonidine.
The molecular mechanisms in whichmoxonidine produce hypoten-
sion and sympathoinhibition are still poorly understood, but some pos-
sibilities would be plausible besides the one described above.
Moxonidine acting on presynaptic α2-AR, located on primary afferent
solitary tract will cause the activation of the Gi-coupled protein to re-
duce intracellular cAMP and decrease the release of neurotransmitters
in the synaptic cleft. One of the neurotransmitters could be the gluta-
mate. Metabotropic glutamate receptors are often located presynapti-
cally on glutamatergic and GABAergic terminals (Thompson et al.,
2004). These metabotropic glutamate receptors provide a negative
feedback, thus decreasing the release of neurotransmitters (Chen
et al., 2002). This could be the mechanism by which moxonidine pro-
duce a reduction in blood pressure and sympathetic activity (present re-
sults; Wang et al., 2007a, b). Taken together, these ﬁndings strongly
suggest that the cardiovascular and sympathetic inhibition evoked by
moxonidine will depend on which brainstem area will be activated to
produce hypotension and sympathoinhibition. Future studies will be
necessary to better understand the role of moxonidine and the possible
interaction between glutamatergic and GABAergic mechanisms.
In summary, we conﬁrm the role of commNTS as an important site
for action of moxonidine and we also showed that the hypotension
and reduction in sympathetic activity elicited by moxonidine depends
on the integrity of GABA, but not ionotropic glutamate mechanisms in
the commNTS region.
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